Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T04:23:20.462Z Has data issue: false hasContentIssue false
  • English
  • Français

Platelet monoamine oxidase activity during the course of a schizophreniform psychosis

Published online by Cambridge University Press:  09 July 2009

Ian B. Cookson ,
Frank Owen  and
A. Pauline Ridges
Ian B. Cookson
Affiliation:
Department of Psychiatry, University of Liverpool
Frank Owen
Affiliation:
Department of Psychiatry, University of Liverpool
A. Pauline Ridges
Affiliation:
Department of Psychiatry, University of Liverpool
Get access Rights & Permissions [Opens in a new window]

Synopsis

A case is reported in which platelet monoamine oxidase (MAO) activity fluctuated in the course of a schizophreniform psychosis in a way which suggests a direct relationship between low levels of MAO activity and the psychosis.

Type
Preliminary Communication
Information
Psychological Medicine , Volume 5 , Issue 3 , August 1975 , pp. 314 - 316
Copyright
Copyright © Cambridge University Press 1975

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beardmore, T. D., Cashman, J. S., and Kelley, W. N. (1972). Mechanism of allopurinol-mediated increase in enzyme activity in man. Journal of Clinical Investigation, 51, 1823–1832.CrossRefGoogle ScholarPubMed
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., and Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.CrossRefGoogle ScholarPubMed
Meltzer, H. Y., and Stahl, S. M. (1974). Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. Research Communications in Chemistry, Pathology and Pharmacology, 7, 419–431.Google ScholarPubMed
Murphy, D. L., and Wyatt, R. (1972). Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature, 238, 225–226.CrossRefGoogle ScholarPubMed
Owen, F., Cookson, I. B., and Ridges, A. P. (1975). Platelet monoamine oxidase activity—a genetic marker for schizophrenia? International Congress Series, 3 No. 3. Excerpta Medica: Amsterdam. (In press.)Google Scholar
Robinson, D. S., Lovenberg, W., Keiser, H., and Sjoerdsma, A. (1968). Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochemical Pharmacology, 17, 109–119.CrossRefGoogle ScholarPubMed
Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H. and Pollin, W. (1973). Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia. Science, 179, 916–918.CrossRefGoogle ScholarPubMed